Wednesday, March 30, 2022
Biz As Usual for Indian Pharma Cos Despite Russia-Ukraine War
Indian drugmakers are continuing to run their operations in Russia, which contributes nearly $600 million of their annual revenues, even as western companies scale down their businesses to comply with global sanctions on Moscow